Vanquish® System is a transurethral, outpatient procedure designed to ablate cancerous prostate tissue using the thermal energy stored in sterile water vapor.

System Overview

The Vanquish System includes capital, disposables and an informative user interface that displays recorded MRI images with real-time ultrasound and cystoscopy to support targeted ablation of cancerous prostate tissue.

Stabilizer System
Allows for hands-free stabilization of devices and freedom of movement

Needle Guidance System (NGS)
Combines with transrectal ultrasound to facilitate lesion targeting

Generator, Cart and Monitor

TRUS Cradle for Ultrasound Probe

Vapor Delivery Device

Advantages of the
Vanquish System

The Vanquish System provides targeted ablation of cancerous lesions in any location in the prostate.

1 Single modality that can treat anywhere in the prostate, including the apex, anterior, or in the transition zone.

2 Transurethral delivery incorporating standard cystoscopy and TRUS.

3 High patient satisfaction results.

4 Low rates of urinary incontinence and erectile dysfunction.

Ability to Safely
Treat Anywhere
in the Prostate

The Vanquish System is able to effectively treat in any location within the prostate, addressing a common limitation of currently available focal therapy options.

Patient Satisfaction Data

Patients participating in the VAPOR 2 study were asked a series of questions about their experience. We continue to gather data on the clinical outcomes and patient experience.

Learn More

93%

of patients were extremely satisfied or satisfied with the Vanquish procedure at 12 months (n=107)

94%

of the patient believed that they Vanquish procedure was a good decision (n=107)

Minimal to No Pain

Most patient reported no pain.

Learn More

In Action: Water Vapor Ablation

Water vapor transfers energy convectively through the target prostate tissue, while respecting the natural boundaries of the prostate. Here are a few examples of water vapor ablation in different areas in the prostate.

Pre-Treatment

Right Apex, Peripheral Zone

Prostate Volume: 38.8 g

Lesion Distance from Apex: 7.75mm

Maximum Lesion Diameter: 8.1mm

7-Day Post-Treatment

No Residual Lesion Detected

Pre-Treatment

Left Anterior Base, Transition Zone
Prostate Volume: 38.3 g
Lesion Distance from Apex: 24mm
Maximum Lesion Diameter: 8.5mm

7-Day Post-Treatment

No Residual Lesion Detected

Pre-Treatment
Right Base, Post-Lateral, Peripheral Zone
Prostate Volume: 55 g
Lesion Distance from Apex: 27mm
Maximum Lesion Diameter: 10mm
7-Day Post-Treatment
No Residual Lesion Detected

We’re Here
To Help.

Francis Medical would love to connect. Follow us on social media or complete the form to ask a question or be added to our company communications.

Let’s Connect